For patients here in the commonwealth and across the country, we’re on the cusp of a new era in cancer care — one that could ...

The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its ...

Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...

Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...

A machine learning program that identified patients overdue for colorectal cancer screening helped increase screening rates ...

Medicine is rapidly evolving from statistical, evidence-based approaches to predictive, genotype-directed care, driven by ...

Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.

In a significant breakthrough for cancer diagnostics, Reliance Industries subsidiary Strand Life Sciences has secured an Indian patent for an artificial intelligence-powered technology that can detect ...

Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...

We're on the cusp of a new era in cancer care – one that could dramatically improve survival and quality of life.

In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance ...

A path has now opened for early prostate cancer diagnosis through urine odor. Professor Koo Kyo-cheol of the Department of ...